Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Common Equity (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Common Equity for 10 consecutive years, with $346.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity fell 2.25% to $346.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $346.6 million, a 2.25% decrease, with the full-year FY2025 number at $346.6 million, down 2.25% from a year prior.
  • Common Equity was $346.6 million for Q4 2025 at Orthopediatrics, down from $349.3 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $383.3 million in Q3 2022 to a low of $215.0 million in Q1 2022.
  • A 5-year average of $323.3 million and a median of $355.0 million in 2024 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: decreased 8.6% in 2021, then soared 73.52% in 2023.
  • Orthopediatrics' Common Equity stood at $225.4 million in 2021, then soared by 68.01% to $378.6 million in 2022, then fell by 0.43% to $377.0 million in 2023, then fell by 5.96% to $354.6 million in 2024, then dropped by 2.25% to $346.6 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Common Equity are $346.6 million (Q4 2025), $349.3 million (Q3 2025), and $355.5 million (Q2 2025).